Schizophrenia prostaglandin

R. Reddy and M. S. Keshavan, Phosphorus magnetic resonance spectroscopy its utility in examining the membrane hypothesis of schizophrenia. Prostaglandins Leukot. Essent. Fatty Acids, 2003,69,401-405. 

Mahadik S. P. and Scheffer R. E. (1996). Oxidative injury and potential use of antioxidants in schizophrenia. Prostaglandins Leukot. Essent. Fatty Acids 55 45-54. 

Vaddadi KS. The use of gamma-linolenic acid and linoleic acid to differentiate between temporal lobe epilepsy and schizophrenia. Prostaglandins Med 1981 6(4) 375-9. 

Gattaz WE, Brunner J. Phospholipase A2 and the hypofrontality hypothesis of schizophrenia. Prostaglandins Leukotrienes and Essential Fatty Acids 1996 55 109-113. 

Kaiya H, Uematsu M, Ofuji M, Nishida A, Takeuchi K, Nozaki M, Idaka E (1989) Elevated plasma prostaglandin E2 levels in schizophrenia. J Neural Transm 77 39 6. 

Horrobin, D.F. (1996) Schizophrenia as a membrane lipid disorder which is expressed throughout the body. Prostaglandins Leukot. Essent. Fatty Acids. 55 3-7. 

Horrobin DF. Schizophrenia as a prostaglandin deficiency disease. Lancet 1977 1 936-937. 

HorrobinDF. Schizophrenia reconciliation of the dopamine, prostaglandin, and opioid concepts and the role of the pineal. Lancet 1979 1 529-531. 

Horrobin DF, Ally Al, Karmali R A, Karmazyn M, Manku MS, Morgan RO. Prostaglandins and schizophrenia further discussion of the evidence. Psychol Med 1978 8 43 8. 

Horrobin DF, Bennett CN. New gene targets related to schizophrenia and other psychiatric disorders enzymes, binding proteins and transport proteins involved in phospholipid and fatty acid metabohsm. Prostaglandins Leukotrienes Essential Fatty Acids 1999 60 111-167. 

---